<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: King Pharma Finds A &#8216;Revenue Deterrent&#8217;</title>
	<atom:link href="http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 18:52:02 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: WEL</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-371090</link>
		<dc:creator>WEL</dc:creator>
		<pubDate>Wed, 03 Sep 2008 16:59:25 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-371090</guid>
		<description>MAXIDEX   WARNING

I had eye surgery and in the post-op pack was   MAXIDEX(dexamethasone) drops by ALCON LABS.

Two days later I was   BLIND

Use Google and enter   EPOCRATES   MAXIDEX   to verify</description>
		<content:encoded><![CDATA[<p>MAXIDEX   WARNING</p>
<p>I had eye surgery and in the post-op pack was   MAXIDEX(dexamethasone) drops by ALCON LABS.</p>
<p>Two days later I was   BLIND</p>
<p>Use Google and enter   EPOCRATES   MAXIDEX   to verify</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ghost in the Machine</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-370934</link>
		<dc:creator>Ghost in the Machine</dc:creator>
		<pubDate>Tue, 02 Sep 2008 18:44:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-370934</guid>
		<description>Aversive addition (that includes antagonists Alpharama) is a losing product proposition. It assumes all of your patients are abusers first as opposed to patients first. The only purpose to use these techniques is to extend product lifecycle. That is all. All of the products currently work as intended if taken as directed. Therefore I think Remoxy is on the right track. It essentially will be the first approved "generic" to OxyContin. It will do the same thing-reduce pain and be dosed the same-2x per day but be able to tell a better story about a certain problem and possibly take market share before Purdue's reformulation is approved. 
Also, show me any study that shows a difference in endpoints on immediate vs. sustained release oxycodone. THEY DO THE SAME THING. So an immediate release tamper resistant would have good uptake because it would be able to take market share away from sustained release oxycodone. Just don't put a poison in it that doesn't work.</description>
		<content:encoded><![CDATA[<p>Aversive addition (that includes antagonists Alpharama) is a losing product proposition. It assumes all of your patients are abusers first as opposed to patients first. The only purpose to use these techniques is to extend product lifecycle. That is all. All of the products currently work as intended if taken as directed. Therefore I think Remoxy is on the right track. It essentially will be the first approved &#8220;generic&#8221; to OxyContin. It will do the same thing-reduce pain and be dosed the same-2x per day but be able to tell a better story about a certain problem and possibly take market share before Purdue&#8217;s reformulation is approved.<br />
Also, show me any study that shows a difference in endpoints on immediate vs. sustained release oxycodone. THEY DO THE SAME THING. So an immediate release tamper resistant would have good uptake because it would be able to take market share away from sustained release oxycodone. Just don&#8217;t put a poison in it that doesn&#8217;t work.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Clemens62</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-370510</link>
		<dc:creator>Clemens62</dc:creator>
		<pubDate>Thu, 28 Aug 2008 06:04:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-370510</guid>
		<description>Regarding the niacin issue which this so called "report" makes light of:

In Acura's 7/06 PR it took an indep lab 1-2 mins to extract 70-90% of the active, abuseable ingredient from Oxycontin, and approx 12 mins to extract 75% or so from Percocet. Then it took the same lab 355 mins (6 hours) to extract a TRACE of the active abuseable ingred from OxyADF. 

Niacin doesnt do THAT. This is way beyond niacin.

Think the word "patent" because you'll be reminded of that word in global proportions once it's FDA approved and is being prescribed.  Keep trying, but the truth that Acura will succeed is going to slap you in the faces.</description>
		<content:encoded><![CDATA[<p>Regarding the niacin issue which this so called &#8220;report&#8221; makes light of:</p>
<p>In Acura&#8217;s 7/06 PR it took an indep lab 1-2 mins to extract 70-90% of the active, abuseable ingredient from Oxycontin, and approx 12 mins to extract 75% or so from Percocet. Then it took the same lab 355 mins (6 hours) to extract a TRACE of the active abuseable ingred from OxyADF. </p>
<p>Niacin doesnt do THAT. This is way beyond niacin.</p>
<p>Think the word &#8220;patent&#8221; because you&#8217;ll be reminded of that word in global proportions once it&#8217;s FDA approved and is being prescribed.  Keep trying, but the truth that Acura will succeed is going to slap you in the faces.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: WEL WHAT</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-369302</link>
		<dc:creator>WEL WHAT</dc:creator>
		<pubDate>Thu, 14 Aug 2008 04:43:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-369302</guid>
		<description>So you cut and paste your post to various sites to which have no relevancy whatsoever.  What's your point?  Not buying it Stevie.

PS
How did you type your message so accurately?

..."Isn't she lovely, isn't she won-der-ful...."</description>
		<content:encoded><![CDATA[<p>So you cut and paste your post to various sites to which have no relevancy whatsoever.  What&#8217;s your point?  Not buying it Stevie.</p>
<p>PS<br />
How did you type your message so accurately?</p>
<p>&#8230;&#8221;Isn&#8217;t she lovely, isn&#8217;t she won-der-ful&#8230;.&#8221;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: WEL</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-369281</link>
		<dc:creator>WEL</dc:creator>
		<pubDate>Wed, 13 Aug 2008 22:05:36 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-369281</guid>
		<description>MAXIDEX   WARNING

I had eye surgery and in the post-op pack was  MAXIDEX(dexamethasone) drops by ALCON LABS.

Two days later I was  BLIND

Use Google and enter  EPOCRATES   MAXIDEDX  to verify</description>
		<content:encoded><![CDATA[<p>MAXIDEX   WARNING</p>
<p>I had eye surgery and in the post-op pack was  MAXIDEX(dexamethasone) drops by ALCON LABS.</p>
<p>Two days later I was  BLIND</p>
<p>Use Google and enter  EPOCRATES   MAXIDEDX  to verify</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: seek_eternal</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-369087</link>
		<dc:creator>seek_eternal</dc:creator>
		<pubDate>Sat, 09 Aug 2008 16:36:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-369087</guid>
		<description>Hey McNamara - 

Explain to the world why your teeny website, here to serve the world, had only one single link the date you (or your counterparts) posted the link online about Acura.  Your site had only one link on the ENTIRE site, and it was to the rant about Acura.

Once you were confronted on it suddenly 24 hours later there were other articles that were linked as well.

Coincidence?  That alone clearly indicated a sole mission to bash Acura, and you guys should have thought about that before you and Castanza posted links to your informative research.</description>
		<content:encoded><![CDATA[<p>Hey McNamara - </p>
<p>Explain to the world why your teeny website, here to serve the world, had only one single link the date you (or your counterparts) posted the link online about Acura.  Your site had only one link on the ENTIRE site, and it was to the rant about Acura.</p>
<p>Once you were confronted on it suddenly 24 hours later there were other articles that were linked as well.</p>
<p>Coincidence?  That alone clearly indicated a sole mission to bash Acura, and you guys should have thought about that before you and Castanza posted links to your informative research.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: cmerx</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-368986</link>
		<dc:creator>cmerx</dc:creator>
		<pubDate>Fri, 08 Aug 2008 15:58:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-368986</guid>
		<description>Looks like the only paranoid one is the writer of this garbage, who immediately jumped on the comments made.  Probably nothing better to do.  Nice try paranoid guy, and best of luck with those short positions.</description>
		<content:encoded><![CDATA[<p>Looks like the only paranoid one is the writer of this garbage, who immediately jumped on the comments made.  Probably nothing better to do.  Nice try paranoid guy, and best of luck with those short positions.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: viking trader</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-368965</link>
		<dc:creator>viking trader</dc:creator>
		<pubDate>Fri, 08 Aug 2008 12:08:22 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-368965</guid>
		<description>sounds like mr. silverman took a page out of   carl rowe's game book.</description>
		<content:encoded><![CDATA[<p>sounds like mr. silverman took a page out of   carl rowe&#8217;s game book.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: I. C. Clearly</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-368901</link>
		<dc:creator>I. C. Clearly</dc:creator>
		<pubDate>Thu, 07 Aug 2008 20:28:30 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-368901</guid>
		<description>This could be the most ridiculous discussion to date.  Folks, BioLogic is a fraud.  I know the people will fix this immediately after I mention it, but click on every article and tell me what you see in the banner heading.  Bush league.</description>
		<content:encoded><![CDATA[<p>This could be the most ridiculous discussion to date.  Folks, BioLogic is a fraud.  I know the people will fix this immediately after I mention it, but click on every article and tell me what you see in the banner heading.  Bush league.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Tuan Hgyuen</title>
		<link>http://www.pharmalot.com/2008/08/king-pharma-finds-a-revenue-deterrent/#comment-368899</link>
		<dc:creator>Tuan Hgyuen</dc:creator>
		<pubDate>Thu, 07 Aug 2008 20:12:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14860#comment-368899</guid>
		<description>hello so you claim the acurox is a fraud, i curious to how you think is a fraud and bogus pharma and bad pharma.  many companies work on develop abuse issue with major addiction problems everywhere, what company do you think has the answer to the problems?  i think not one single answer but many and we see if fda approval</description>
		<content:encoded><![CDATA[<p>hello so you claim the acurox is a fraud, i curious to how you think is a fraud and bogus pharma and bad pharma.  many companies work on develop abuse issue with major addiction problems everywhere, what company do you think has the answer to the problems?  i think not one single answer but many and we see if fda approval</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.160 seconds -->

